- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about MRSN
Recent news which mentions MRSN
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 03, 2023
From Benzinga
Mersana Inks Cancer Therapy Development Deal With Merck Germany
December 23, 2022
From Benzinga
Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session
December 19, 2022
From Benzinga
Mersana Therapeutics's Return On Capital Employed Insights
November 30, 2022
Tickers
MRSN
From Benzinga
Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday
November 08, 2022
From Benzinga
Myovant Sciences And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
October 24, 2022
From Benzinga
Why Nauticus Robotics Shares Are Trading Higher By 96%; Here Are 67 Biggest Movers From Yesterday
October 06, 2022
From Benzinga
Important Biotech Catalysts For September 12, 2022 - End Of The Day Summary
September 12, 2022
From Benzinga
Mersana Shares Climb As FDA Grants Fast Track Status To Triple-Negative Breast Cancer Candidate
September 12, 2022
Tickers
MRSN
From Benzinga
Mersana Therapeutics's Return On Capital Employed Insights
September 01, 2022
Tickers
MRSN
From Benzinga
Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary
August 16, 2022
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
August 09, 2022
From Benzinga
Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday's Mid-Day Session
August 09, 2022
From Benzinga
From Benzinga
Biotech Daily: Regulatory Setback For CorMedix, Mersana & GSK In Cancer Pact, BARDA Funding For Opioid Overdose Hopeful
August 09, 2022
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
August 09, 2022
From Benzinga
Mersana, GSK Ink $1.36B Biobuck Deal For Cancer-Focused Therapy
August 09, 2022
From Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
August 08, 2022
From Benzinga
Earnings Scheduled For August 8, 2022
August 08, 2022
From Benzinga
89 Biggest Movers From Friday
June 21, 2022
From Benzinga
Executives Buy Around $17M Of 5 Penny Stocks
May 19, 2022
From Benzinga
From Benzinga
Earnings Scheduled For May 9, 2022
May 09, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.